Detalles de la búsqueda
1.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer
; 27(2): 375-386, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281295
2.
Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.
Int J Clin Oncol
; 29(4): 386-397, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381163
3.
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma.
Esophagus
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467986
4.
A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer.
Br J Cancer
; 129(7): 1176-1183, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37543670
5.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871043
6.
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
Gastric Cancer
; 26(2): 307-316, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695982
7.
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study.
Gastric Cancer
; 26(4): 614-625, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029843
8.
A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006.
Future Oncol
; 19(28): 1897-1904, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37750332
9.
Phase II biomarker identification study of anti-VEGF agents with FOLFIRI for pretreated metastatic colorectal cancer.
Future Oncol
; 19(23): 1593-1600, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584156
10.
Prognostic factors associated with the transition in treatment methods for brain metastases from colorectal cancer.
Int J Clin Oncol
; 28(8): 1043-1053, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208499
11.
Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan.
Int J Clin Oncol
; 28(8): 990-998, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37115427
12.
Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903).
Int J Clin Oncol
; 28(8): 1063-1072, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286878
13.
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 329(15): 1271-1282, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071094
14.
Current Targeted Therapy for Metastatic Colorectal Cancer.
Int J Mol Sci
; 24(2)2023 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675216
15.
Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
Br J Cancer
; 127(6): 1043-1050, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35715628
16.
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
Support Care Cancer
; 30(5): 4497-4504, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113224
17.
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.
Int J Clin Oncol
; 27(9): 1450-1458, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861943
18.
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.
Cancer Sci
; 112(4): 1567-1578, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548159
19.
Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study.
BMC Cancer
; 21(1): 294, 2021 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743636
20.
Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
Dis Colon Rectum
; 64(11): 1331-1341, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34623347